Too much processed meat and not enough fruits and whole grains are the leading risk factors for diet-related GI cancers.

A new blood test was found to detect colon cancer with more than 80% accuracy — and to rule it out for 90% of healthy people.

【2025年ASCO胃肠道肿瘤专题研讨会（ASCO GI，Gastrointestinal Cancers Symposium）是全球胃肠道肿瘤领域的顶级学术盛会之一，已于2025年1月23日至25日在美国加利福尼亚州旧金山举办完毕。此次会议汇集了全球胃肠道肿瘤领域的临床和基础研究最新进展，重点讨论包括肝癌、胃癌、结直肠癌、胰腺癌等多种消化道恶性肿瘤的诊治策略和创新疗法。本号近期将对2025 AS ...

In 2024, 6,889 cancer patients visited the institute, up from around 3,500 in 2020, with majority suffering from ...

Association between skeletal muscle morphometrics and overall survival among older adults with gastrointestinal cancers. Gene rearrangements/fusions identified per year.

Opdivo plus chemo showed long-term survival advantages in Chinese patients with advanced gastric, gastroesophageal junction ...

Marwan G. Fakih, MD, discussed the implications of the findings from the phase 2 study for patients with microsatellite ...

Perspective Therapeutics shares interim results for [212Pb]VMT-α-NET trial, showing promising safety, stable disease cases, ...

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new stu ...

Bristol Myers Squibb’s Opdivo plus Yervoy, as well as Pfizer’s Braftovi, have each shown strong Phase III performances that ...

At the recent ASCO Gastrointestinal Cancers symposium, Cyclacel Ltd. presented preclinical data for the Polo-like kinase 1 (PLK1) inhibitor plogosertib from assessment in models of colorectal cancer.